Multiple-dose pharmacokinetic and pharmacodynamic interaction between ABT-335, rosuvastatin and warfarin.

Trial Profile

Multiple-dose pharmacokinetic and pharmacodynamic interaction between ABT-335, rosuvastatin and warfarin.

Completed
Phase of Trial: Phase I

Latest Information Update: 27 Sep 2012

At a glance

  • Drugs Choline fenofibrate; Rosuvastatin; Warfarin
  • Indications Atherosclerosis; Cardiovascular disorders; Hypercholesterolaemia; Hyperlipidaemia; Hypertriglyceridaemia; Thrombosis
  • Focus Pharmacodynamics; Pharmacokinetics
  • Sponsors Abbott Laboratories
  • Most Recent Events

    • 08 Oct 2010 Actual end date (July 2007) added as reported by ClinicalTrials.gov.
    • 06 Dec 2007 Status changed from in progress to completed.
    • 13 Jul 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top